Efficacy and Safety of a Novel Intradermal Live-attenuated Varicella Zoster Vaccine in Hematopoietic Stem Cell Transplantation Donors: a Randomized Double Blind Placebo-controlled Trial
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Varicella zoster virus vaccine live (Primary) ; Varicella zoster virus vaccine live (Primary) ; Imiquimod
- Indications Varicella zoster virus infections
- Focus Pharmacodynamics
- Acronyms VZIDST
- 27 Jul 2017 Planned primary completion date changed from 1 Nov 2017 to 1 Mar 2018.
- 02 Dec 2015 Planned number of patients changed from 120 to 160, as reported by ClinicalTrials.gov.
- 02 Dec 2015 Number of treatment arms changed from 4 to 5,treatment section revised with inclusion of one additional treatment arm "ID VZVv with imiquimod group".Also, planned number of subjects changed from 120 to 160.